Sino Biopharmaceutical Limited
SBMFF
$0.9891
$0.03914.12%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.96% | 9.18% | -16.10% | -20.02% | -18.85% |
| Total Receivables | 6.57% | 14.12% | 2.18% | -2.59% | -3.05% |
| Inventory | 15.65% | 23.83% | -9.16% | -13.41% | -16.74% |
| Prepaid Expenses | 15.76% | 23.95% | 35.62% | 29.28% | 21.68% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 0.74% | 7.87% | -6.69% | -11.06% | -10.72% |
|
|
|||||
| Total Current Assets | 0.74% | 7.87% | -6.69% | -11.06% | -10.72% |
| Net Property, Plant & Equipment | 0.83% | 7.97% | 0.77% | -3.94% | 4.22% |
| Long-term Investments | 30.73% | 39.98% | -13.86% | -17.88% | -0.11% |
| Goodwill | 30.73% | 39.98% | -13.86% | -17.88% | -0.11% |
| Total Other Intangibles | 6.29% | 13.82% | 13.52% | 8.21% | -13.17% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -25.14% | -19.85% | -32.33% | -35.49% | 35.69% |
| Total Assets | -0.10% | 6.97% | 1.42% | -3.32% | -3.43% |
|
|
|||||
| Total Accounts Payable | 8.99% | 16.71% | 0.91% | -3.80% | -31.08% |
| Total Accrued Expenses | 10.68% | 18.51% | -- | -- | 3.70% |
| Short-term Debt | -- | -- | -- | -- | -2.73% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -33.86% | -29.18% | -19.27% | -23.05% | 12.11% |
| Total Finance Division Other Current Liabilities | -16.02% | -10.07% | -20.83% | -24.53% | 48.26% |
| Total Other Current Liabilities | -16.02% | -10.07% | -20.83% | -24.53% | 48.26% |
| Total Current Liabilities | -15.96% | -10.01% | -18.46% | -22.27% | 9.12% |
|
|
|||||
| Total Current Liabilities | -15.96% | -10.01% | -18.46% | -22.27% | 9.12% |
| Long-Term Debt | 80.54% | 93.32% | 43.57% | 36.86% | -73.43% |
| Short-term Debt | -- | -- | -- | -- | -2.73% |
| Capital Leases | -72.85% | -70.93% | -53.12% | -55.31% | -10.49% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -33.42% | -28.71% | 14.00% | 8.67% | -17.31% |
| Total Liabilities | -13.55% | -7.43% | -15.93% | -19.86% | -5.29% |
|
|
|||||
| Common Stock & APIC | -3.02% | 3.84% | -0.38% | -5.03% | -3.04% |
| Retained Earnings | 3.85% | 11.20% | 10.97% | 5.78% | -18.88% |
| Treasury Stock & Other | 0.88% | -6.14% | -2.64% | 2.16% | 49.03% |
| Total Common Equity | 1.89% | 9.10% | 9.30% | 4.19% | -0.35% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.89% | 9.10% | 9.30% | 4.19% | -0.35% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 36.51% | 46.17% | 43.10% | 36.41% | -8.68% |
| Total Equity | 8.87% | 16.57% | 15.30% | 9.91% | -2.15% |
|
|
|||||